Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert McBane
Academic and Community Cancer Research United
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Mayo Clinic in Florida
Jacksonville, Florida, United States
- Northshore University Healthsystem-Evanston Hospital
Evanston, Illinois, United States
- Illinois Cancercare-Peoria
Peoria, Illinois, United States
- University of Iowa/holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- Siouxland Regional Cancer Center
Sioux City, Iowa, United States
- Cancer Center of Kansas - Wichita
Wichita, Kansas, United States
- Cancer Research Consortium of West Michigan Ncorp
Grand Rapids, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Coborn Cancer Center at Saint Cloud Hospital
Saint Cloud, Minnesota, United States
- Metro Minnesota Community Oncology Research Consortium
Saint Louis Park, Minnesota, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- New Hampshire Oncology Hematology Pa-Hooksett
Hooksett, New Hampshire, United States
- Firsthealth of the Carolinas-Moore Regional Hosiptal
Pinehurst, North Carolina, United States
- Columbus Nci Community Oncology Research Program
Columbus, Ohio, United States
- Toledo Clinic Cancer Centers-Toledo
Toledo, Ohio, United States
- Guthrie Medical Group Pc-Robert Packer Hospital
Sayre, Pennsylvania, United States
- Rapid City Regional Hospital
Rapid City, South Dakota, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Nov 2015
- Primary completion
- 2 Apr 2018
- Completion
- 24 Dec 2019
- Last update posted
- 4 Aug 2020
- Registered enrollment
- 300
- Registry id
- NCT02585713
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.